How Increasing Medical Access to Opioids Contributes to the Opioid Epidemic
Evidence from Medicare Part D
ResearchPosted on rand.org Jun 26, 2020Published in: Journal of Health Economics, Volume 71 (May 2020). doi: 10.1016/j.jhealeco.2019.102286
Evidence from Medicare Part D
ResearchPosted on rand.org Jun 26, 2020Published in: Journal of Health Economics, Volume 71 (May 2020). doi: 10.1016/j.jhealeco.2019.102286
Drug overdoses involving opioid analgesics have increased dramatically since 1999, representing one of the United States' top public health crises. Opioids have legitimate medical functions, but they are often diverted, suggesting a tradeoff between improving medical access and nonmedical abuse. We provide causal estimates of the relationship between the medical opioid supply and drug overdoses using Medicare Part D as a differential shock to the geographic distribution of opioids. Our estimates imply that a 10% increase in opioid medical supply leads to a 7.1% increase in opioid-related deaths among the Medicare-ineligible population, suggesting substantial diversion from medical markets.
This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.